Sotera Health appoints Christopher A. Simon to board of directors

Sotera Health Co

Board increased from 11 to 12 directors; Simon appointed as Class III director effective August 1, 2024.
Simon is President & CEO of Haemonetics Corporation and will serve on the Leadership Development and Compensation Committee.
Simon is independent under Nasdaq Rule 5605(a)(2); no arrangement or reportable transactions with the company.
As non-employee director, Simon will receive standard cash retainer and annual restricted stock unit grant.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christopher A. Simon

Class III director

SHC · Sotera Health Co

Effective: 2024-08-01
Filed: August 1, 2024, 7:59 PM ET

On July 31, 2024, the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) increased the size of the Board from eleven directors to twelve directors and appointed Christopher A. Simon as a Class III director of the Board, effective August 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Christopher A. Simon was appointed as Class III director at Sotera Health Co.

Action: appointed
Role: Class III director

Exact text from the filing

On July 31, 2024, the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) increased the size of the Board from eleven directors to twelve directors and appointed Christopher A. Simon as a Class III director of the Board, effective August 1, 2024.

View on SEC.gov

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001822479-24-000036

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.